Retrospective cohort study of trifluridine/tipiracil (TAS-102) plus bevacizumab versus trifluridine/tipiracil monotherapy for metastatic colorectal cancer

BACKGROUND: A previous phase I/II C-TASK FORCE study of trifluridine/tipiracil plus bevacizumab for patients with heavily pretreated metastatic colorectal cancer (mCRC) showed promising activity with an acceptable toxicity profile. This retrospective study aimed to investigate the safety and efficac...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:BMC Cancer
Asıl Yazarlar: Kotani, Daisuke, Kuboki, Yasutoshi, Horasawa, Satoshi, Kaneko, Asumi, Nakamura, Yoshiaki, Kawazoe, Akihito, Bando, Hideaki, Taniguchi, Hiroya, Shitara, Kohei, Kojima, Takashi, Tsuji, Akihito, Yoshino, Takayuki
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2019
Konular:
Research Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC6935149/
https://ncbi.nlm.nih.gov/pubmed/31881856
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12885-019-6475-6
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller